Christian S. Shinaberger, MPH, Ryan D. Kilpatrick, MS, Deborah L

Slides:



Advertisements
Similar presentations
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Advertisements

by Kamyar Kalantar-Zadeh, Ryan D. Kilpatrick, Charles J
Renal Function Testing
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Peritoneal dialysis American Journal of Kidney Diseases
Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
Association of Relatively Low Serum Parathyroid Hormone With Malnutrition- Inflammation Complex and Survival in Maintenance Hemodialysis Patients  Ramanath.
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD 
The US Renal Data System “Pie Chart of Death”
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial  Hao Yan, MD, Wei Fang, MD,
Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.
Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V
Jayme E. Locke, MD, MPH  American Journal of Kidney Diseases 
Evaluation of the Potential Living Kidney Donor
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Wayne Trebbin, MD, Peter Monteleone, MD 
Salt and Hypertension American Journal of Kidney Diseases
Let Them Eat During Dialysis: An Overlooked Opportunity to Improve Outcomes in Maintenance Hemodialysis Patients  Kamyar Kalantar-Zadeh, MD, MPH, PhD,
Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD.
Dietary Management of Incremental Transition to Dialysis Therapy: Once-Weekly Hemodialysis Combined With Low-Protein Diet  Piergiorgio Bolasco, MD, Adamasco.
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS 
This Month in AJKD American Journal of Kidney Diseases
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot?  Bertram L. Kasiske, MD  American Journal of Kidney.
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States  Mae Thamer, PhD, Yi Zhang, DDS, MS,
Julie A. Wright Nunes, MD, MPH, Kerri L
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients  Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.
Prevalence and Severity of Renal Disease in Familial Dysautonomia
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD 
Drug Dose Adjustments in Patients With Renal Impairment
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Nutritional management of dialysis patients: Balancing among nutrient intake, dialysis dose, and nutritional status  Toshiyuki Nakao, MD, Hiroshi Matsumoto,
Risk for Incident Renal Dialysis in a Managed Care Population
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Removal of Dabigatran by Hemodialysis
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
American Journal of Kidney Diseases
Making Music American Journal of Kidney Diseases
Why measure serum albumin levels?
The Use of Vaccines in Adult Patients With Renal Disease
August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD 
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Anil K. Saxena, MD, B.R. Panhotra, MD, PhD, MNAMS 
Supportive care for patients with renal disease: Time for action
Soluble CD14 and Endotoxin Levels in Hemodialysis Patients: A Tale of 2 Molecules  Victor F. Seabra, MD, George Thomas, MD, MPH, Bertrand L. Jaber, MD,
This Month in AJKD American Journal of Kidney Diseases
Dialysis Research and N-of-1 Trials: Made for Each Other?
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Mortality predictability of the difference of the percentiles of the changes in dietary protein intake, represented by nPNA (nPCR), and serum P concentration.
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Presentation transcript:

Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis Patients  Christian S. Shinaberger, MPH, Ryan D. Kilpatrick, MS, Deborah L. Regidor, MPH, Charles J. McAllister, MD, Sander Greenland, DrPH, Joel D. Kopple, MD, Kamyar Kalantar-Zadeh, MD, MPH, PhD  American Journal of Kidney Diseases  Volume 48, Issue 1, Pages 37-49 (July 2006) DOI: 10.1053/j.ajkd.2006.03.049 Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Association between nPNA and 2-year mortality in all 53,933 MHD patients of DaVita dialysis clinics based on time-dependent models using quarterly varying repeated measures. American Journal of Kidney Diseases 2006 48, 37-49DOI: (10.1053/j.ajkd.2006.03.049) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Association between nPNA and 2-year mortality in only the 47,119 MHD patients without significant residual renal function (urinary urea clearance = 0) using time-dependent models and quarterly varying repeated measures. American Journal of Kidney Diseases 2006 48, 37-49DOI: (10.1053/j.ajkd.2006.03.049) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 3 Association between nPNA and 2-year mortality in 22,023 incident MHD patients (dialysis vintage < 6 months) based on time-dependent models using quarterly varying repeated measures. American Journal of Kidney Diseases 2006 48, 37-49DOI: (10.1053/j.ajkd.2006.03.049) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Association between nPNA and 2-year mortality in 31,910 prevalent MHD patients (dialysis vintage > 6 months) based on time-dependent models using quarterly varying repeated measures. American Journal of Kidney Diseases 2006 48, 37-49DOI: (10.1053/j.ajkd.2006.03.049) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 5 Association between change in nPNA (nPCR) during the first 6 months and death in the subsequent 18 months in patients with a baseline nPNA of 0.8 to 1.2 g/kg/d. American Journal of Kidney Diseases 2006 48, 37-49DOI: (10.1053/j.ajkd.2006.03.049) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 6 Hypothetical association between dietary protein intake and survival in MHD patients and the possible role of other factors. Whereas case-mix, comorbidity, and dialysis dose may be confounders, MICS may be in the causal pathway of the association between protein intake and survival. American Journal of Kidney Diseases 2006 48, 37-49DOI: (10.1053/j.ajkd.2006.03.049) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions